Age 85+ years accelerates large-fiber peripheral nerve dysfunction and diabetes contributes even in the oldest-old: The women's health and aging study

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 56, Issue 1, 2001, Pages

  Resnick, H E ^a   Vinik, A I ^a   Heimovitz, H K ^a   Brancati, F L ^a   Guralnik, J M ^a  

^a MEDSTAR HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CORRELATION FUNCTION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0035161935     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/56.1.M25     Document Type: Article

References (41)

1. Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey, 1988-1994
2. Symptoms of sensory neuropathy in adults with NIDDM in the US population
3. Sensory neuropathy in non-insulin dependent diabetes mellitus: The San Luis Valley Diabetes Study
4. The Rochester Diabetic Neuropathy Study: Design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests
5. Epidemiologic correlates of diabetic neuropathy
6. Diabetes in the elderly: The Oxford Community Diabetes Study
7. Risk factors for diabetic peripheral sensory neuropathy
8. Peripheral somatic nerve function in relation to glucose tolerance in an elderly Caucasian population: The Hoorn Study
9. Factors in development of diabetic neuropathy
10. Age-related change in peripheral nerve conduction: Compound muscle action potential duration and dispersion
11. The effects of age and diabetes mellitus on nerve function
12. Variables influencing neuropathic endpoints: The Rochester Diabetic Neuropathy Study of Healthy Subjects
13. Chronic symmetric polyneuropathy in the elderly: A field screening investigation of risk factors for polyneuropathy in two Italian communities
14. Effects of age on complications in adults onset diabetes
15. Hyperglycemia as a major determinant of distal polyneuropathy independent of age and diabetes duration in patients with recently diagnosed diabetes
16. Screening the community-dwelling population for disability
17. Measuring diabetic neuropathy. Assessment and comparison of clinical examination and quantitative sensory testing
18. Estimating stature from knee height for persons 60 to 90 years of age
19. Gait abnormalities in diabetic neuropathy
20. The relationship of peripheral motor nerve conduction velocity to age-associated loss of grip strength
21. Moderate peripheral neuropathy impairs weight transfer and unipedal balance in the elderly
22. Peripheral neuropathy: A true risk factor for falls
23. Differences in the gait characteristics of patients with diabetes and peripheral neuropathy compared with age-matched controls
24. Reported and measured physical functioning in older inner-city diabetic African-Americans
25. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia
26. Impairment of peripheral blood flow responses in diabetes resembles an enhanced aging effect
27. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus
28. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation
29. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in the US population aged 20-74 yr
30. Localization in human diabetic peripheral nerve of N(epison)-carboxymethllysine-protein adducts, an advanced glycation endproduct
31. Diagnosis and management of diabetic neuropathy
32. Quantitative measurement of cutaneous perception in diabetic neuropathy
33. Report and recommendations of the San Antonio Conference on Diabetic Neuropathy
34. Cigarette smoking and neuropathy in diabetic patients
35. Measurement of markers of osteoclast and osteoblast activity in patients with acute and chronic diabetic Charcot neuroarthropathy
36. Normal blood flow and vasomotion in the diabetic Charcot foot